Update October 2, 2013: ITN's sample sharing program, previously managed through BioShare, has been integrated into ITN's clinical trials portal, TrialShare. Please visit ITNTrialShare.org to learn more about or gain access to ITN clinical trial samples.
We are pleased to announce BioShare, a new Biomarker Sample Sharing opportunity from the Immune Tolerance Network (ITN). Interested investigators are invited to visit the BioShare website (www.itnbioshare.org) for information and access to clinical samples collected from ITN trials.
The ITN develops and conducts trials of novel immune tolerance therapies in type 1 diabetes and other autoimmune diseases, solid organ and islet transplantation, allergy and asthma. The ITN has stored hundreds of thousands of biospecimens from clinically well-phenotyped subjects that have participated in its trials, representing an important resource for future investigations. Samples collected from ITN trials that remain after performance of the protocol-specified assays are available for further studies through this BioShare website, the ITN's portal for sharing clinical samples with the scientific community.
To gain access to ITN samples, investigators from the scientific community are invited to submit research proposals through this website, anytime during the year. Proposals for use of ITN samples will undergo scientific review by the ITN. Please visit the website for more detailed information and proposal submission instructions: www.itnbioshare.org
Contact:
ITNCommunications@immunetolerance.org
Immune Tolerance Network
Office of the Director
1201 Ninth Avenue, IN-RC
Seattle, WA 98101-2795
P: 206-341-0688